Cargando…

Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease

Alzheimer’s disease (AD), a progressive neurodegenerative disorder characterized by memory loss and cognitive decline, is a major cause of death and disability among the older population. Despite decades of scientific research, the underlying etiological triggers are unknown. Recent studies suggeste...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Pradeep K., Delotterie, David F., Xiao, Jianfeng, Pierre, Joseph F., Rao, RadhaKrishna, McDonald, Michael P., Khan, Mohammad Moshahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067249/
https://www.ncbi.nlm.nih.gov/pubmed/33916001
http://dx.doi.org/10.3390/cells10040779
_version_ 1783682758946586624
author Shukla, Pradeep K.
Delotterie, David F.
Xiao, Jianfeng
Pierre, Joseph F.
Rao, RadhaKrishna
McDonald, Michael P.
Khan, Mohammad Moshahid
author_facet Shukla, Pradeep K.
Delotterie, David F.
Xiao, Jianfeng
Pierre, Joseph F.
Rao, RadhaKrishna
McDonald, Michael P.
Khan, Mohammad Moshahid
author_sort Shukla, Pradeep K.
collection PubMed
description Alzheimer’s disease (AD), a progressive neurodegenerative disorder characterized by memory loss and cognitive decline, is a major cause of death and disability among the older population. Despite decades of scientific research, the underlying etiological triggers are unknown. Recent studies suggested that gut microbiota can influence AD progression; however, potential mechanisms linking the gut microbiota with AD pathogenesis remain obscure. In the present study, we provided a potential mechanistic link between dysbiotic gut microbiota and neuroinflammation associated with AD progression. Using a mouse model of AD, we discovered that unfavorable gut microbiota are correlated with abnormally elevated expression of gut NLRP3 and lead to peripheral inflammasome activation, which in turn exacerbates AD-associated neuroinflammation. To this end, we observe significantly altered gut microbiota compositions in young and old 5xFAD mice compared to age-matched non-transgenic mice. Moreover, 5xFAD mice demonstrated compromised gut barrier function as evident from the loss of tight junction and adherens junction proteins compared to non-transgenic mice. Concurrently, we observed increased expression of NLRP3 inflammasome and IL-1β production in the 5xFAD gut. Consistent with our hypothesis, increased gut–microbial–inflammasome activation is positively correlated with enhanced astrogliosis and microglial activation, along with higher expression of NLRP3 inflammasome and IL-1β production in the brains of 5xFAD mice. These data indicate that the elevated expression of gut–microbial–inflammasome components may be an important trigger for subsequent downstream activation of inflammatory and potentially cytotoxic mediators, and gastrointestinal NLRP3 may promote NLRP3 inflammasome-mediated neuroinflammation. Thus, modulation of the gut microbiota may be a potential strategy for the treatment of AD-related neurological disorders in genetically susceptible hosts.
format Online
Article
Text
id pubmed-8067249
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80672492021-04-25 Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease Shukla, Pradeep K. Delotterie, David F. Xiao, Jianfeng Pierre, Joseph F. Rao, RadhaKrishna McDonald, Michael P. Khan, Mohammad Moshahid Cells Article Alzheimer’s disease (AD), a progressive neurodegenerative disorder characterized by memory loss and cognitive decline, is a major cause of death and disability among the older population. Despite decades of scientific research, the underlying etiological triggers are unknown. Recent studies suggested that gut microbiota can influence AD progression; however, potential mechanisms linking the gut microbiota with AD pathogenesis remain obscure. In the present study, we provided a potential mechanistic link between dysbiotic gut microbiota and neuroinflammation associated with AD progression. Using a mouse model of AD, we discovered that unfavorable gut microbiota are correlated with abnormally elevated expression of gut NLRP3 and lead to peripheral inflammasome activation, which in turn exacerbates AD-associated neuroinflammation. To this end, we observe significantly altered gut microbiota compositions in young and old 5xFAD mice compared to age-matched non-transgenic mice. Moreover, 5xFAD mice demonstrated compromised gut barrier function as evident from the loss of tight junction and adherens junction proteins compared to non-transgenic mice. Concurrently, we observed increased expression of NLRP3 inflammasome and IL-1β production in the 5xFAD gut. Consistent with our hypothesis, increased gut–microbial–inflammasome activation is positively correlated with enhanced astrogliosis and microglial activation, along with higher expression of NLRP3 inflammasome and IL-1β production in the brains of 5xFAD mice. These data indicate that the elevated expression of gut–microbial–inflammasome components may be an important trigger for subsequent downstream activation of inflammatory and potentially cytotoxic mediators, and gastrointestinal NLRP3 may promote NLRP3 inflammasome-mediated neuroinflammation. Thus, modulation of the gut microbiota may be a potential strategy for the treatment of AD-related neurological disorders in genetically susceptible hosts. MDPI 2021-04-01 /pmc/articles/PMC8067249/ /pubmed/33916001 http://dx.doi.org/10.3390/cells10040779 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shukla, Pradeep K.
Delotterie, David F.
Xiao, Jianfeng
Pierre, Joseph F.
Rao, RadhaKrishna
McDonald, Michael P.
Khan, Mohammad Moshahid
Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease
title Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease
title_full Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease
title_fullStr Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease
title_full_unstemmed Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease
title_short Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease
title_sort alterations in the gut-microbial-inflammasome-brain axis in a mouse model of alzheimer’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067249/
https://www.ncbi.nlm.nih.gov/pubmed/33916001
http://dx.doi.org/10.3390/cells10040779
work_keys_str_mv AT shuklapradeepk alterationsinthegutmicrobialinflammasomebrainaxisinamousemodelofalzheimersdisease
AT delotteriedavidf alterationsinthegutmicrobialinflammasomebrainaxisinamousemodelofalzheimersdisease
AT xiaojianfeng alterationsinthegutmicrobialinflammasomebrainaxisinamousemodelofalzheimersdisease
AT pierrejosephf alterationsinthegutmicrobialinflammasomebrainaxisinamousemodelofalzheimersdisease
AT raoradhakrishna alterationsinthegutmicrobialinflammasomebrainaxisinamousemodelofalzheimersdisease
AT mcdonaldmichaelp alterationsinthegutmicrobialinflammasomebrainaxisinamousemodelofalzheimersdisease
AT khanmohammadmoshahid alterationsinthegutmicrobialinflammasomebrainaxisinamousemodelofalzheimersdisease